Results

Bristol-Myers Squibb Company

05/15/2021 | Press release | Distributed by Public on 05/15/2021 10:47

Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Demonstrating Health Status Benefits of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy at American[...]